GlassScriptPhysician profile
Elenora Vidal-Pascal
NPI 1861952715
$9,024.32
in general payments reported to CMS, 2019-2025
58 companies · $2,327 in 2025
The $2,327 reported for 2025 was more than what 95% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,369 · 2022: $1,637 · 2023: $1,690 · 2024: $2,000 · 2025: $2,327.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,908 · Education: $110.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,907.94 |
| Education | $109.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $965.30 | 2021-2025 | Opdivo, Opdualag |
| Astrazeneca Pharmaceuticals LP | $912.90 | 2021-2025 | Enhertu, Imfinzi, Tagrisso |
| Celgene Corporation | $799.84 | 2021-2025 | Reblozyl, Opdualag, Opdivo |
| Merck Sharp & Dohme LLC | $502.31 | 2021-2025 | Keytruda, Welireg, Lynparza |
| Janssen Biotech, INC. | $498.52 | 2021-2025 | Erleada, Talvey, Darzalex |
| Gilead Sciences, INC. | $411.94 | 2022-2025 | Trodelvy |
| Jazz Pharmaceuticals INC. | $393.79 | 2021-2025 | |
| Daiichi Sankyo INC. | $325.38 | 2021-2025 | Enhertu, Datroway |
| Genzyme Corporation | $302.23 | 2021-2025 | |
| Abbvie INC. | $291.43 | 2021-2025 | |
| Seagen INC. | $262.55 | 2021-2023 | Adcetris, Tukysa |
| Eisai INC. | $253.50 | 2021-2025 | |
| Ipsen Biopharmaceuticals, INC | $244.82 | 2023-2025 | Onivyde, Somatuline Depot |
| Lilly USA, LLC | $231.36 | 2021-2024 | Jaypirca, Verzenio, Retevmo |
| Glaxosmithkline, LLC. | $210.25 | 2021-2025 | Ojjaara, Jemperli, Zejula |
Show all 58 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $199.73 | 2023-2025 | |
| Amgen INC. | $188.52 | 2021-2023 | Lumakras |
| Incyte Corporation | $136.06 | 2022-2025 | Monjuvi, Pemazyre, Jakafi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $121.07 | 2021-2025 | Gilotrif |
| Exelixis INC. | $116.50 | 2022-2025 | Cabometyx |
| Octapharma USA, INC. | $107.28 | 2021 | |
| Taiho Oncology, INC. | $106.78 | 2021-2024 | |
| Stemline Therapeutics INC. | $105.91 | 2023-2025 | Orserdu |
| Takeda Pharmaceuticals U.S.A., INC. | $103.65 | 2021-2025 | Fruzaqla, Alunbrig |
| Sanofi-Aventis U.S. LLC | $99.95 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $90.26 | 2024-2025 | Libtayo |
| Bayer Healthcare Pharmaceuticals INC. | $85.76 | 2022-2024 | |
| Genentech USA, INC. | $83.94 | 2024-2025 | Polivy, Itovebi |
| Pfizer INC. | $77.42 | 2023-2025 | |
| Sobi, INC | $64.18 | 2024-2025 | |
| Astellas Pharma US INC | $59.63 | 2024-2025 | Padcev, Vyloy, Xospata |
| G1 Therapeutics, INC. | $57.62 | 2022-2023 | Cosela |
| Array Biopharma INC | $47.62 | 2023-2025 | Braftovi, Mektovi, Tukysa |
| Emd Serono, INC. | $41.36 | 2022-2023 | Bavencio |
| Morphosys, US INC. | $37.93 | 2022-2023 | Monjuvi |
| Dendreon Pharmaceuticals LLC | $34.22 | 2025 | Provenge |
| Puma Biotechnology, INC. | $29.89 | 2021-2024 | |
| Genmab U.S., INC. | $29.78 | 2024 | Epkinly |
| Coherus Oncology, INC. | $29.00 | 2021 | |
| Karyopharm Therapeutics INC. | $27.54 | 2021 | |
| Pharmaessentia USA Corporation | $26.99 | 2022-2025 | Besremi |
| Mirati Therapeutics, INC. | $26.39 | 2023-2024 | Krazati |
| Deciphera Pharmaceuticals INC. | $25.03 | 2025 | Romvimza, Qinlock |
| Blueprint Medicines Corporation | $23.86 | 2024 | Ayvakit |
| Geron Corporation | $23.85 | 2025 | Rytelo |
| Rigel Pharmaceuticals, INC. | $22.34 | 2022-2024 | Tavalisse, Rezlidhia |
| Iovance Biotherapeutics, INC. | $20.69 | 2025 | Amtagvi |
| Novocure INC. | $19.11 | 2025 | Optune Lua (Novottf-200t) |
| Legend Biotech USA INC. | $18.22 | 2025 | Carvykti |
| Pharmacosmos Therapeutics INC. | $17.86 | 2025 | Monoferric |
| Aveo Pharmaceuticals, INC. | $17.11 | 2024 | |
| Servier Pharmaceuticals LLC | $16.34 | 2024 | |
| Csl Behring | $15.31 | 2022 | |
| Immunocore Limited | $14.54 | 2024 | Kimmtrak |
| Myovant Sciences INC. | $12.70 | 2021 | |
| Myriad Genetic Laboratories, INC. | $12.43 | 2022 | |
| Sun Pharmaceutical Industries INC. | $12.43 | 2021 | |
| Emmaus Medical, INC. | $11.40 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elenora Vidal-Pascal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.